Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coagulation factor IIa, also known as thrombin, is the active form of prothrombin (coagulation factor II). It is a serine protease that plays a central role in blood coagulation by converting soluble fibrinogen into insoluble fibrin strands, forming the structural basis of a blood clot. Thrombin activates other coagulation factors, platelets, and has roles in cell proliferation, tissue repair, and angiogenesis. Dysregulation of thrombin activity can lead to thrombosis or bleeding disorders.
Serine protease that cleaves Arg-Gly bonds within target proteins, such as fibrinogen, to activate them. Inhibitors can bind to the active site, preventing substrate binding and thus its enzymatic function.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coagulation Factor IIa (F2a).